Switzerland could sell or give away AstraZeneca doses if regulator dithers

2/21/2021 2:35:39 PM

(MENAFN- Swissinfo) A lack of green light from medicines regulator Swissmedic could see 5.3 million doses ordered by Switzerland sent elsewhere.

This content was published on February 21, 2021 - 11:36 February 21, 2021 - 11:36 swissinfo.ch/ac

The absence of anti-Covid vaccine AstraZeneca from a delivery plan shared last week by the army has raised questions about the fate of the vaccine. The British manufacturer accounts for a seventh of the country's vaccine dose orders.

On Sunday, the paper NZZ am Sonntag wrote that the federal government is considering selling or giving away the Swiss quota if market approval continues to be delayed or is eventually denied. The review is dragging on since October because the competent authority, Swissmedic, has requested additional clinical data from a study in the US.

Nora Kronig, who is in charge of vaccine procurement, told the NZZ am Sonntag that the data situation is currently uncertain, which is why AstraZeneca is not listed in the delivery plan. She added that withdrawal from the sales contract is not an option at the moment but said the order would be reexamined if the vaccine fails to get approval.

MENAFN21022021000210011054ID1101636313

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.